The effect of Norepinephrine on the prevention of post spinal hypotensio

Phase 2

Recruiting

• Conditions: Spinal anesthesia in cesarean section.

• Registration Number: IRCT20120915010841N24
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 126

Inclusion Criteria

Satisfaction to participate in the project
Pregnant women aged 18 to 46 and term pregnancy
Candidate for cesarean section under spinal anesthesia

Exclusion Criteria

Patients who have failed spinal anesthesia and undergo general anesthesia
Lung disease, heart disease, fever, hypertension, diabetes and cardiac arrhythmia
Emergency cesarean section due to meconium and fetal distress
preeclampsia and eclampsia
Multiple pregnancies
Contraindications to spinal anesthesia (high ICP, hypovolemia, anemia, coagulation disorders, etc.)
History of taking ergotamine
Initial systolic pressure less than 90 mmHg

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: Every two minutes to 10 minutes, then every 5 minutes to 15 minutes, and every 10 minutes until the end of the surgery. Method of measurement: Automatic non-invasive blood pressure device.

Secondary Outcome Measures

Name	Time	Method
Heart Rate. Timepoint: Every two minutes to 10 minutes, then every 5 minutes to 15 minutes, and every 10 minutes until the end of the surgery. Method of measurement: pulse oximetry.;Nausea and Vomiting. Timepoint: During and after surgery. Method of measurement: Observation.;New born Apgar. Timepoint: 1&5 minutes after delivery. Method of measurement: Apgar Score.;The amount of ephedrine have been consumed. Timepoint: During surgery. Method of measurement: mg.;The amount of atropine have been consumed. Timepoint: During surgery. Method of measurement: mg.